These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26772440)

  • 1. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.
    Anderson JL; May HT; Lappé DL; Bair T; Le V; Carlquist JF; Muhlestein JB
    Am J Cardiol; 2016 Mar; 117(5):794-9. PubMed ID: 26772440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
    Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
    Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.
    Oni OA; Dehkordi SHH; Jazayeri MA; Sharma R; Sharma M; Masoomi R; Sharma R; Gupta K; Barua RS
    Am J Cardiol; 2019 Oct; 124(8):1171-1178. PubMed ID: 31409450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Safety of Testosterone-Replacement Therapy.
    Lincoff AM; Bhasin S; Flevaris P; Mitchell LM; Basaria S; Boden WE; Cunningham GR; Granger CB; Khera M; Thompson IM; Wang Q; Wolski K; Davey D; Kalahasti V; Khan N; Miller MG; Snabes MC; Chan A; Dubcenco E; Li X; Yi T; Huang B; Pencina KM; Travison TG; Nissen SE;
    N Engl J Med; 2023 Jul; 389(2):107-117. PubMed ID: 37326322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
    Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.
    Corona G; Monami M; Boddi V; Cameron-Smith M; Fisher AD; de Vita G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2010 Apr; 7(4 Pt 1):1557-64. PubMed ID: 20102478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low testosterone and sexual symptoms in men with acute coronary syndrome can be used to predict major adverse cardiovascular events during long-term follow-up.
    Chmiel A; Mizia-Stec K; Wierzbicka-Chmiel J; Rychlik S; Muras A; Mizia M; Bienkowski J
    Andrology; 2015 Nov; 3(6):1113-8. PubMed ID: 26460501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
    Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
    Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
    Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
    JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.
    Yeap BB; Alfonso H; Chubb SA; Hankey GJ; Handelsman DJ; Golledge J; Almeida OP; Flicker L; Norman PE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4565-73. PubMed ID: 25268392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.